dc.contributor.author |
Fahmy, Omar |
|
dc.contributor.author |
Stenzl, Arnulf |
|
dc.contributor.author |
Gakis, Georgios |
|
dc.date.accessioned |
2018-11-13T14:46:12Z |
|
dc.date.available |
2018-11-13T14:46:12Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
1573-7276 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/84890 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Springer |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1007/s10585-016-9807-9 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
The current status of checkpoint inhibitors in metastatic bladder cancer |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20180405102126_01009 |
|
utue.publikation.seiten |
629-635 |
de_DE |
utue.personen.roh |
Fahmy, Omar |
|
utue.personen.roh |
Khairul-Asri, Mohd Ghani |
|
utue.personen.roh |
Stenzl, Arnulf |
|
utue.personen.roh |
Gakis, Georgios |
|
dcterms.isPartOf.ZSTitelID |
Clinical & Experimental Metastasis |
de_DE |
dcterms.isPartOf.ZS-Issue |
7 |
de_DE |
dcterms.isPartOf.ZS-Volume |
33 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |